Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
OKI, YASUHIRO
One or more keywords matched the following items that are connected to OKI, YASUHIRO
Item TypeName
Concept Vinblastine
Academic Article Does rituximab have a place in treating classic hodgkin lymphoma?
Academic Article Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Academic Article Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barr? syndrome: a case report.
Academic Article Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
Academic Article Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
Academic Article Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score.
Academic Article Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?
Academic Article Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Academic Article ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study.
Academic Article Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy.
Academic Article Older patients (aged =60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.
Search Criteria
  • Vinblastine